Relationship between Depression and Medication Adherence in Patients with Multiple Sclerosis in Qazvin

Introduction and purpose: Multiple sclerosis (MS) is a chronic, autoimmune, inflammatory disease of the central nervous system that remains an incurable disease. Pharmacological treatment aims to minimize the debilitating symptoms, slow disease progression, and protect the quality of life. Medication adherence is one of the main success factors in the treatment of this chronic disease, which is influenced by various factors. This study aimed to determine the relationship between depression and medication adherence in patients with MS. Methods: This descriptive-analytical study was conducted on 200 patients with MS referred to Bu Ali Sina Hospital and Multiple Sclerosis Association in Qazvin City, Iran, in 2023. Patients were included in the study following convenience sampling. Data were collected by demographic checklist, Morisky Medication Adherence Scale (MMAS-8), and Beck Depression Inventory (BDI). Bivariate and multivariate logistic regression analyses were carried out using the SPSS-v25 software. Results: The mean and standard deviation of the scores of medication adherence and depression were 6.93±1.66 and 36.19±10.26, respectively. In 23.3% of the participants, the level of medication adherence was low, and depression was at moderate (30.5%) and severe levels (69.5%). In the multivariate regression analysis, with an increase in depression scores, the odds of non-adherence to treatment increased by 1.72 times, and patients suffering from more severe depression had lower medication adherence (P<0.0001). The odds of non-adherence to treatment in patients receiving oral medications compared to those receiving injectable medications was 2.144 times higher (P<0.039), and in unemployed patients compared to employed patients, it was 0.286 times higher (P<0.046). Conclusion: Depression has a significant negative impact on medication adherence in MS patients. Employment status and type of prescribed drugs are related to medication adherence in these patients. Therefore, the role of these factors should be taken into account when designing educational, caring, and supportive interventions.

Institutions

Publication Details

Journal
SHILAP Revista de lepidopterología
Published
2025-01-01
Primary Topic
Diverse Scientific and Economic Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Relationship between Depression and Medication Adherence in Patients with Multiple Sclerosis in Qazvin

SHILAP Revista de lepidopterología
Diverse Scientific and Economic Studies
article

Relationship between Depression and Medication Adherence in Patients with Multiple Sclerosis in Qazvin

article en

Abstract

Introduction and purpose: Multiple sclerosis (MS) is a chronic, autoimmune, inflammatory disease of the central nervous system that remains an incurable disease. Pharmacological treatment aims to minimize the debilitating symptoms, slow disease progression, and protect the quality of life. Medication adherence is one of the main success factors in the treatment of this chronic disease, which is influenced by various factors. This study aimed to determine the relationship between depression and medication adherence in patients with MS. Methods: This descriptive-analytical study was conducted on 200 patients with MS referred to Bu Ali Sina Hospital and Multiple Sclerosis Association in Qazvin City, Iran, in 2023. Patients were included in the study following convenience sampling. Data were collected by demographic checklist, Morisky Medication Adherence Scale (MMAS-8), and Beck Depression Inventory (BDI). Bivariate and multivariate logistic regression analyses were carried out using the SPSS-v25 software. Results: The mean and standard deviation of the scores of medication adherence and depression were 6.93±1.66 and 36.19±10.26, respectively. In 23.3% of the participants, the level of medication adherence was low, and depression was at moderate (30.5%) and severe levels (69.5%). In the multivariate regression analysis, with an increase in depression scores, the odds of non-adherence to treatment increased by 1.72 times, and patients suffering from more severe depression had lower medication adherence (P<0.0001). The odds of non-adherence to treatment in patients receiving oral medications compared to those receiving injectable medications was 2.144 times higher (P<0.039), and in unemployed patients compared to employed patients, it was 0.286 times higher (P<0.046). Conclusion: Depression has a significant negative impact on medication adherence in MS patients. Employment status and type of prescribed drugs are related to medication adherence in these patients. Therefore, the role of these factors should be taken into account when designing educational, caring, and supportive interventions.

SHILAP Revista de lepidopterología
Mulago School of Nursing and Midwifery (UG), Qazvin University of Medical Sciences (IR)
Openalex Percentile: Top 39%
Diverse Scientific and Economic Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.